---
title: The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival
  of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health
  Administration
date: '2023-12-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38151390/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20231228170629&v=2.18.0
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSION: Our study shows that a TDT equal to or less than 1 week
  is associated with adverse clinical factors, worse outcomes, and response in DLBCL,
  even after adjusting for multiple known poor prognostic factors. This was the first
  time that response to first-line therapy was correlated to time to treatment. Our
  findings support ongoing efforts to improve currently standardized prognostic tools
  and the incorporation of TDT into clinical trials to avoid selection ...'
disable_comments: true
---
CONCLUSION: Our study shows that a TDT equal to or less than 1 week is associated with adverse clinical factors, worse outcomes, and response in DLBCL, even after adjusting for multiple known poor prognostic factors. This was the first time that response to first-line therapy was correlated to time to treatment. Our findings support ongoing efforts to improve currently standardized prognostic tools and the incorporation of TDT into clinical trials to avoid selection ...